UNSPSC 51434004: Rilmakalim

This classification denotes an antihypertensive agent with the molecular formula C21H23NO5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47Y56T6LEI, chemically known as 2-pyrrolidinone, 1-(3,4-dihydro-3-hydroxy-2,2-dimethyl-6-(phenylsulfonyl)-2h-1-benzopyran-4-yl)-, (3s-trans)- but generally known as rilmakalim, which bears US NIH Compound Identifier 65966. European Medicines Agency schedules Rilmakalim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10314MIG.

UNSPSC 51434004 Rilmakalim, a Commodity code, covers emergency medical medications supplied to state and local fire rescue and paramedic services for field administration during advanced life support scenarios. State and local governments procure this code primarily through city fire departments and rescue services, which issue sealed-bid solicitations for specific injectable medications—including vasopressors, antiarrhythmics, and rate-control agents—in vial form with strict expiration-date and delivery-turnaround requirements. Suppliers must warrant medications free from defects for a minimum of 365 days and arrange pickup and replacement of expired stock before the nine-month expiration threshold. Issuing bodies are primarily municipal fire departments operating within larger jurisdictions, often acting through city purchasing offices; the code does not show school districts, transit authorities, or county-level solicitations in recent activity. Solicitations typically incorporate small business preferences and set-asides where applicable, along with mandatory OSHA compliance documentation (Safety Data Sheets) and accessibility conformance reporting.

The City of Tampa's Purchasing Department posted a representative sealed-bid solicitation (26P00188, due April 8, 2026) for Advanced Life Support Medications on behalf of Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00. The bid called for 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, delivered within ten calendar days of order receipt, with a one-year initial term and options for two additional one-year renewals plus up to three unilateral 30-day extensions. The solicitation included a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount capped at $10,000. Recent activity is concentrated in Florida; the source shows no sufficient geographic spread to characterize multi-state trends or other jurisdictions pursuing this code at present.